Shares

11 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2022

Feb 13, 2023

BUY
$0.74 - $1.83 $1.04 Million - $2.56 Million
1,399,741 Added 46.74%
4,394,415 $3.91 Million
Q3 2022

Nov 14, 2022

BUY
$1.51 - $2.88 $1.88 Million - $3.58 Million
1,243,608 Added 71.02%
2,994,674 $4.7 Million
Q2 2022

Aug 12, 2022

SELL
$1.24 - $2.33 $892,323 - $1.68 Million
-719,616 Reduced 29.13%
1,751,066 $3.52 Million
Q1 2022

May 13, 2022

BUY
$2.0 - $4.9 $3.24 Million - $7.94 Million
1,620,162 Added 190.49%
2,470,682 $5.76 Million
Q4 2021

Feb 10, 2022

BUY
$4.65 - $7.23 $2.13 Million - $3.3 Million
457,080 Added 116.18%
850,520 $3.96 Million
Q3 2021

Nov 10, 2021

BUY
$7.41 - $10.99 $736,235 - $1.09 Million
99,357 Added 33.79%
393,440 $3 Million
Q2 2021

Aug 10, 2021

SELL
$6.35 - $10.0 $196,723 - $309,800
-30,980 Reduced 9.53%
294,083 $2.85 Million
Q1 2021

May 10, 2021

BUY
$7.03 - $16.51 $1.45 Million - $3.41 Million
206,611 Added 174.43%
325,063 $2.69 Million
Q4 2020

Feb 10, 2021

SELL
$5.76 - $11.95 $1.13 Million - $2.34 Million
-195,498 Reduced 62.27%
118,452 $808,000
Q3 2020

Nov 13, 2020

BUY
$6.17 - $18.82 $1.19 Million - $3.63 Million
193,048 Added 159.67%
313,950 $3.5 Million
Q2 2020

Aug 07, 2020

BUY
$1.73 - $6.76 $209,160 - $817,297
120,902 New
120,902 $759,000

Others Institutions Holding SRNE

About Sorrento Therapeutics, Inc.


  • Ticker SRNE
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 449,952,000
  • Market Cap $148M
  • Description
  • Sorrento Therapeutics, Inc., a clinical stage and commercial biopharmaceutical company, develops therapies for cancer, autoimmune, inflammatory, viral, and neurodegenerative diseases. It operates through two segments, Sorrento Therapeutics and Scilex. The company provides cancer therapeutic by leveraging its proprietary G-MAB antibody library an...
More about SRNE
Track This Portfolio

Track Rafferty Asset Management, LLC Portfolio

Follow Rafferty Asset Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Rafferty Asset Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Rafferty Asset Management, LLC with notifications on news.